Sterile Preparation Produced under strict sterile conditions for research-safe reconstitution of lyophilized peptides
Individuals with B12 deficiency may be more susceptible to infections and have a weakened immune response
Cyanocob 1000 helps animals recover from nutritional deficiencies, improves feed conversion and supports growth in young animals
At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
Because CJC-1295 (No DAC) is short-acting, it avoids the prolonged GH elevation and possible receptor downregulation associated with DAC versions
5-Amino-1MQ is a synthetic research compound studied in laboratory models involving NNMT research, metabolic pathway analysis, enzyme activity, molecular signaling, biochemical mechanisms, and cellular biology
